Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?

Hendrik Ungefroren; Björn Konukiewitz; Rüdiger Braun; Ulrich Friedrich Wellner; Tobias Keck; Jens Uwe Marquardt

doi:10.3390/cancers15030581

Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?

Hendrik Ungefroren^*, Björn Konukiewitz, Rüdiger Braun, Ulrich Friedrich Wellner, Tobias Keck, Jens Uwe Marquardt

^*Korrespondierende/r Autor/-in für diese Arbeit

Christian-Albrechts Universität zu Kiel

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related mortality worldwide, with a 5-year-survival rate below 10% that is the lowest of all cancer types [...].

Originalsprache	Englisch
Aufsatznummer	581
Zeitschrift	Cancers
Jahrgang	15
Ausgabenummer	3
ISSN	2072-6694
DOIs	https://doi.org/10.3390/cancers15030581
Publikationsstatus	Veröffentlicht - 18.01.2023

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Dokumente

10.3390/cancers15030581

Weitere Links

Fingerprint

Untersuchen Sie die Forschungsthemen von „Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren

Ungefroren, H., Konukiewitz, B., Braun, R., Wellner, U. F., Keck, T., & Marquardt, J. U. (2023). Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma? Cancers, 15(3), Artikel 581. https://doi.org/10.3390/cancers15030581

@article{31489449f6bb4097a8ab7c30e5c7cbec,

title = "Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?",

abstract = "Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related mortality worldwide, with a 5-year-survival rate below 10% that is the lowest of all cancer types [...].",

author = "Hendrik Ungefroren and Bj{\"o}rn Konukiewitz and R{\"u}diger Braun and Wellner, {Ulrich Friedrich} and Tobias Keck and Marquardt, {Jens Uwe}",

year = "2023",

month = jan,

day = "18",

doi = "10.3390/cancers15030581",

language = "English",

volume = "15",

journal = "Cancers",

issn = "2072-6694",

number = "3",

}

Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma? / Ungefroren, Hendrik; Konukiewitz, Björn; Braun, Rüdiger et al.
in: Cancers, Jahrgang 15, Nr. 3, 581, 18.01.2023.

Publikation: Beiträge in Fachzeitschriften › Leitartikel

TY - JOUR

T1 - Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity

T2 - Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?

AU - Ungefroren, Hendrik

AU - Konukiewitz, Björn

AU - Braun, Rüdiger

AU - Wellner, Ulrich Friedrich

AU - Keck, Tobias

AU - Marquardt, Jens Uwe

PY - 2023/1/18

Y1 - 2023/1/18

N2 - Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related mortality worldwide, with a 5-year-survival rate below 10% that is the lowest of all cancer types [...].

AB - Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related mortality worldwide, with a 5-year-survival rate below 10% that is the lowest of all cancer types [...].

UR - http://www.scopus.com/inward/record.url?scp=85147813229&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/152c372b-63a5-35a7-a619-c095caa98d1e/

U2 - 10.3390/cancers15030581

DO - 10.3390/cancers15030581

M3 - Editorial

C2 - 36765537

AN - SCOPUS:85147813229

SN - 2072-6694

VL - 15

JO - Cancers

JF - Cancers

IS - 3

M1 - 581

ER -